期刊文献+

多系统脾虚证的临床和实验研究 被引量:6

Clinical and Experimental Studies on Spleen-Asthenia Syndroms
原文传递
导出
摘要 本文通过临床症状的观察及唾液淀粉酶活性、D-木糖排泄率的检测,对消化系统及非消化系统进行多系统脾虚证的同步观察,以了解脾虚证某些检测指标的特异性及不同系统脾虚证的共同特点。本研究观察了正常对照18例43个系统10个病种共43例病例,分为脾虚证组、肝胄不和证组、痰热证组及正常人组,对其中42例患者作了前后对照观察,临床痊愈占71.45%,显效占19.05%,好转占7.14%,无效占2.38%。各组分别同步观察淀粉酶活性及D-木糖排泄率,结果表明脾虚患者在安静状态下酶活性较正常人显著为高(P<0.05),酶活性比值小于1;其D-木糖排泄率虽较正常及其他对照组为低,但无显著性差异(P>0.05)。脾虚证多系统间各指标的两两比较表明,唾液淀粉酶活性及D-木糖排泄率均无显著性差异(P>0.05)。 Forty-three patients with 10 different kinds of diseases in 3 systemswere classified into 3 groups:spleen-asthenia,incordination of liver andstomach,phlegm-heat syndrome,and 18 healty volunteers as control.The result of treatment on 42 patients showed that 71.45% were cured,19.05% markedly effective,7.14% improved and 2.38% ineffectlve. The result of the experimental study showed that the salivin activity in spleen-asthenia group was significantly higher than that of the healthy volunteers in quiet state(p<0.05),the salivin activity ratio being less than 1,and the D-xylose excretion rate was lower than other groups, but there was no significant difference (p>0.05). The salivin activities and D-xylise excretion rates of spleen-asthenia syndrome from the diseases of different systems had no significant difference(p>0.05).
作者 何羿婷
出处 《广州中医学院学报》 1995年第1期16-20,共5页
关键词 脾虚 诊断 唾液 淀粉酶类 木糖 尿 SPLEEN ASTHENIA/diag.SALIVA/anal.AMYLASES/anal.XYLOSE/urine.
  • 相关文献

参考文献2

二级参考文献1

  • 1沈自尹,王文健.中医虚证辨证参考标准[J]中西医结合杂志,1986(10).

共引文献34

同被引文献89

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部